Paradoxical effects of prenatal acetylcholinesterase blockade on neuro-behavioral development and drug-induced stereotypies in reeler mutant mice

Psychopharmacology

Volumn 187, Issue 3, 2006, Pages 331-344

  Laviola, Giovanni ^a   Adriani, Walter ^a   Gaudino, Chiara ^b   Marino, Ramona ^b   Keller, Flavio ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Amphetamine; Autism; Chlorpyrifos oxon; Gene environment interaction; Schizophrenia; Scopolamine

Indexed keywords

ACETYLCHOLINESTERASE; AMPHETAMINE; CHLORPYRIFOS; CHOLINESTERASE INHIBITOR; PESTICIDE; REELIN; SCOPOLAMINE;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOPAMINERGIC SYSTEM; EPIGENETICS; FEMALE; GENOTYPE; GESTATION PERIOD; HEREDITY; HETEROZYGOSITY; HOMOZYGOSITY; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; REARING; REFLEX; RIGHTING REFLEX; STEREOTYPY; VOCALIZATION; WILD TYPE;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CELL ADHESION MOLECULES, NEURONAL; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FETUS; GROWTH; MALE; MICE; MICE, NEUROLOGIC MUTANTS; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; REFLEX; SERINE ENDOPEPTIDASES; STEREOTYPED BEHAVIOR; VOCALIZATION, ANIMAL;

EID: 33746096547     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0426-z     Document Type: Article

References (59)

1. Adriani W, Laviola G (2000) A unique hormonal and behavioral hyporesponsivity to both forced novelty and d-amphetamine in periadolescent mice. Neuropharmacology 39:334-346
2. Aldridge JE, Meyer A, Seidler FJ, Slotkin TA (2005) Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure. Environ Health Perspect 113:1027-1031
3. Ballmaier M, Zoli M, Leo G, Agnati LF, Spano P (2002) Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia. Eur J Neurosci 15:1197-1205
4. Betancourt AM, Carr RL (2004) The effect of chlorpyrifos and chlorpyrifos-oxon on brain cholinesterase, muscarinic receptor binding, and neurotrophin levels in rats following early postnatal exposure. Toxicol Sci 77:63-71
5. Branchi I, Campolongo P, Alleva E (2003) Scopolamine effects on ultrasonic vocalization emission and behavior in the neonatal mouse. Behav Brain Res 151:9-16
6. Bymaster FP, Felder C, Ahmed S, McKinzie D (2002) Muscarinic receptors as a target for drugs treating schizophrenia. Curr Drug Targets CNS Neurol Disord 1:163-181
7. 3H]thymidine autoradiography. Brain Res 256:293-302
8. Chanda SM, Pope CN (1996) Neurochemical and neurobehavioral effects of repeated gestational exposure to chlorpyrifos in maternal and developing rats. Pharmacol Biochem Behav 53:771-776
9. Chanda SM, Harp P, Liu J, Pope CN (1995) Comparative developmental and maternal neuro-toxicity following acute gestational exposure to chlorpyrifos in rats. J Toxicol Environ Health 44:189-202
10. Cole TB, Walter BJ, Shih DM, Tward AD, Lusis AJ, Timchalk C, Richter RJ, Costa LG, Furlong CE (2005) Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenet Genomics 15:589-598
11. Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C (2001) Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis 8: 723-742
12. Costa E, Davis J, Pesold C, Tueting P, Guidotti A (2002) The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr Opin Pharmacol 2: 56-62
13. D'Arcangelo G, Miao GG, Curran T (1996) Detection of the reelin breakpoint in reeler mice. Brain Res Mol Brain Res 39:234-236
14. Dong H, Xiang YY, Farchi N, Ju W, Wu Y, Chen L, Wang Y, Hochner B, Yang B, Soreq H, Lu WY (2004) Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons. J Neurosci 24:8950-8960
15. Ellman GL, Courtney KD, Andres V Jr, Feather-stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95
16. Elwood RW, Keeling F (1982) Temporal organization of ultrasonic vocalisation in infant mice. Dev Psychobiol 15:221-227
17. Fatemi SH (2001) Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol Psychiatry 6:129-133
18. Fox WM (1965) Reflex ontogeny and behavioural development of the mouse. Anim Behav 13:234-244
19. Friedman JI (2004) Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists. Psychopharmacology 174:45-53
20. Furlong CE, Li WF, Costa LG, Richter RJ, Shih DM, Lusis AJ (1998) Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism. Neurotoxicology 19:645-650
21. Furlong CE, Cole TB, Jarvik GP, Pettan-Brewer C, Geiss GK, Richter RJ, Shih DM, Tward AD, Lusis AJ, Costa LG (2005) Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants. Neurotoxicology 26:651-659
22. Garcia-Ayllon MS, Segui D, Perales M, Lopez-Hurtado E, Prieto JJ, Saez-Valero J (2003) Acetylcholinesterase level and molecular isoforms are altered in brain of reelin Orleans mutant mice. J Neurochem 87:773-779
23. Gottesman II, Hanson DR (2005) Human development: biological and genetic processes. Annu Rev Psychol 2:263-286
24. Granon S, Faure P, Changeux JP (2003) Executive and social behaviors under nicotinic receptor regulation. Proc Natl Acad Sci USA 100:9596-9601
25. Gronier B, Perry KW, Rasmussen K (2000) Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area. Psychopharmacology 147:347-355
26. Hyde TM, Crook JM (2001) Cholinergic systems and schizophrenia: primary pathology or epiphenomena? J Chem Neuroanat 22:53-63
27. Icenogle LM, Christopher NC, Blackwelder WP, Caldwell DP, Qiao D, Seidler FJ, Slotkin TA, Levin ED (2004) Behavioral alterations in adolescent and adult rats caused by a brief subtoxic exposure to chlorpyrifos during neurulation. Neurotoxicol Teratol 26:95-101
28. Ichikawa J, Chung YC, Li Z, Dai J, Meltzer HY (2002) Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res 958:176-184
29. Keller F, Persico AM (2003) The neurobiological context of autism. Mol Neurobiol 28:1-22
30. Laviola G, Renna G, Bignami G, Cuomo V (1988) Ontogenetic and pharmacological dissociation of various components of locomotor activity and habituation in the rat. Int J Dev Neurosci 6:431-438
31. Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, Iversen P, Bauman M, Perry E (2002) Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 125:1483-1495
32. Levin ED, Addy N, Baruah A, Elias A, Christopher NC, Seidler FJ (2002) Prenatal chlorpyrifos exposure in rats causes persistent behavioural alterations. Neurotoxicol Teratol 24:733-741
33. Liu J, Chakraborti T, Pope C (2002) In vitro effects of organophosphorus anticholinesterases on muscarinic receptor-mediated inhibition of acetylcholine release in rat striatum. Toxicol Appl Pharmacol 178:102-108
34. Ma W, Maric D, Li BS, Hu Q, Andreadis JD, Grant GM, Liu QY, Shaffer KM, Chang YH, Zhang L, Pancrazio JJ, Pant HC, Stenger DA, Barker JL (2000) Acetylcholine stimulates cortical precursor cell proliferation in vitro via muscarinic receptor activation and MAP kinase phosphorylation. Eur J Neurosci 12:1227-1240
35. Martin MR (1981) Acetylcholinesterase-positive fibers and cell bodies in the cochlear nuclei of normal and reeler mutant mice. J Comp Neurol 197:153-167
36. Martin-Ruiz CM, Lee M, Perry RH, Baumann M, Court JA, Perry EK (2004) Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res 123:81-90
37. Mathur A, Shandarin A, LaViolette SR, Parker J, Yeomans JS (1997) Locomotion and stereotypy induced by scopolamine: contributions of muscarinic receptors near the pedunculopontine tegmental nucleus. Brain Res 775:144-155
38. Mount HT, Dreyfus CF, Black IB (1994) Muscarinic stimulation promotes cultured Purkinje cell survival: a role for acetylcholine in cerebellar development? J Neurochem 63:2065-2073
39. Nishikawa S, Goto S, Yamada K, Hamasaki T, Ushio Y (2003) Lack of Reelin causes malpositioning of nigral dopaminergic neurons: evidence from comparison of normal and Reln(rl) mutant mice. J Comp Neurol 461:166-173
40. Niu S, Renfro A, Quattrocchi CC, Sheldon M, D'Arcangelo G (2004) Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron 41:71-84
41. Pappas GD, Kriho V, Pesold C (2001) Reelin in the extracellular matrix and dendritic spines of the cortex and hippocampus: a comparison between wild type and heterozygous reeler mice by immunoelectron microscopy. J Neurocytol 30:413-425
42. Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL (2001) Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 158:1058-1066
43. Phelps PE, Rich R, Dupuy-Davies S, Rios Y, Wong T (2002) Evidence for a cell-specific action of Reelin in the spinal cord. Dev Biol 244:180-198
44. Qiao D, Seidler FJ, Tate CA, Cousins MM, Slotkin TA (2003) Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood. Environ Health Perspect 111:536-544
45. Riley BP, McGuffin P (2000) Linkage and associated studies of schizophrenia. Am J Med Genet 97:23-44
46. Salinger WL, Ladrow P, Wheeler C (2003) Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation. Behav Neurosci 117:1257-1275
47. Schiffmann SN, Bernier B, Goffinet AM (1997) Reelin mRNA expression during mouse brain development. Eur J Neurosci 9:1055-1071
48. Shannon HE, Rasmussen K, Bymaster FP, Hart JC, Peters SC, Swedberg MD, Jeppesen L, Sheardown MJ, Sauerberg P, Fink-Jensen A (2000) Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. Schizophr Res 42:249-259
49. Slotkin TA, Seidler FJ (2005) The alterations in CNS serotonergic mechanisms caused by neonatal chlorpyrifos exposure are permanent. Brain Res Dev Brain Res 158:115-119
50. Staton DM, Solomon PR (1984) Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affects stereotypy and locomotion in the rat. Physiol Psychol 12:159-162
51. Tandon R (1999) Cholinergic aspects of schizophrenia. Br J Psychiatry 37:7-11
52. Tandon R, Shipley JE, Greden JF, Mann NA, Eisner WH, Goodson JA (1991) Muscarinic cholinergic hyperactivity in schizophrenia. Relationship to positive and negative symptoms. Schizophr Res 4:23-30
53. Teitelbaum O, Benton T, Shah PK, Prince A, Kelly JL, Teitelbaum P (2004) Eshkol-Wachman movement notation in diagnosis: the early detection of Asperger's syndrome. Proc Natl Acad Sci USA 101:11909-11914
54. Tirelli E, Laviola G, Adriani W (2003) Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents. Neurosci Biobehav Rev 27:163-178
55. Tueting P, Costa E, Dwivedi Y, Guidotti A, Impagnatiello F, Manev R, Pesold C (1999) The phenotypic characteristics of heterozygous reeler mouse. Neuroreport 10:1329-1334
56. Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J (2002) Reelin and ApoE receptors cooperate to enhance hippocarapal synaptic plasticity and learning. J Biol Chem 277:39944-39952
57. Whyatt RM, Barr DA (2001) Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: a validation study. Environ Health Perspect 109:417-420
58. Yeomans J, Baptista M (1997) Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol Biochem Behav 57:915-921
59. Zhang H, Liu J, Pope CN (2002) Age-related effects of chlorpyrifos on muscarinic receptor-mediated signaling in rat cortex. Arch Toxicol 75:676-684